Genetic Factors in Skin Rash and Contact Dermatitis

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on skin & genetics. Browse all Skin & Genetics education

A rash that flares when your skin meets certain metals, fragrances, or chemicals is often contact dermatitis. Why do some people react to nickel or a new lotion while others never do? Part of the answer lies in genes that build your skin barrier and process the compounds your skin encounters.

What Is Contact Dermatitis?

Contact dermatitis is skin inflammation triggered by contact with an irritant or an allergen — common culprits include nickel, fragrances, preservatives, and certain plants. It comes in two main forms: irritant (direct damage) and allergic (an immune-driven response). Both are influenced by how strong your skin barrier is and how your body handles chemical exposures, which is where genetics enters the picture.

The Skin Barrier and the FLG (Filaggrin) Gene

Filaggrin, encoded by the FLG gene, is a protein essential for a strong, well-hydrated skin barrier. Loss-of-function variants such as R501X and 2282del4 reduce filaggrin, leaving the barrier leakier and more permeable to irritants and allergens. FLG mutations are the strongest known genetic risk factor for atopic dermatitis (eczema) and also raise susceptibility to irritant contact dermatitis, because a compromised barrier lets more of a substance reach the immune cells beneath.

Detox Genes: GSTM1, GSTT1, and NAT2

Your skin also has to process the chemicals it meets. The glutathione S-transferase genes GSTM1 and GSTT1 help neutralize reactive compounds; a common null genotype means the enzyme is absent, and research links these null genotypes to higher contact-dermatitis susceptibility for certain allergens. The NAT2 gene governs acetylator status, affecting how quickly you process some chemical allergens. Slow acetylators may respond differently to specific exposures than fast acetylators.

The immune system supplies a third layer. Allergic contact dermatitis is a delayed hypersensitivity reaction, and genes in the HLA family — which present foreign molecules to immune cells — help determine which substances your body flags as threats. Variation in inflammatory signaling genes can influence how vigorously the skin reacts once an allergen is recognized. Barrier strength, chemical processing, and immune response together explain why reactions are so individual.

What the Research Shows

Studies consistently show FLG loss-of-function variants increase eczema and barrier-related dermatitis risk across populations. Research on GSTM1 and GSTT1 null genotypes and NAT2 acetylator status has found associations with allergic contact dermatitis to particular substances, such as hair-dye and fragrance components, though findings vary by allergen and population. These are pathway-level tendencies, not guarantees of a reaction.

Genetics, Triggers, and Working With a Provider

Genetics shapes susceptibility, but exposure is what triggers a rash. Identifying and avoiding your specific triggers — often through patch testing done by a dermatologist or allergist — remains the cornerstone of management. Knowing you carry a weaker-barrier or slower-detox profile can motivate barrier-supportive skin care and careful product choices, and it makes for a more informed conversation with your provider about testing and next steps.

What Your Genetic Insights Reveal

The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants tied to skin-barrier integrity and chemical-processing pathways. It does not diagnose or treat any skin condition. It shows the biological tendencies you carry — context you can bring to a dermatologist or allergist. Genetics is a guide, not a guarantee.

Frequently Asked Questions

Is contact dermatitis genetic?

Susceptibility to contact dermatitis has a genetic component, but exposure triggers the rash. Genes like FLG affect skin-barrier strength, while GSTM1 and GSTT1 influence how skin processes chemicals. Carrying these variants raises the odds of reacting to certain irritants or allergens, not the certainty.

What does the FLG gene have to do with rashes?

FLG encodes filaggrin, a protein that keeps the skin barrier strong and hydrated. Loss-of-function FLG variants weaken that barrier, letting irritants and allergens penetrate more easily. This raises the risk of eczema and irritant contact dermatitis, which is why FLG is a key skin-genetics gene.

Can a genetic test tell me what I am allergic to?

No. A genetic test does not diagnose allergies or identify specific triggers. Patch testing by a dermatologist or allergist does that. Genetic insight describes barrier and chemical-processing tendencies at the pathway level, which you can discuss with a provider alongside proper allergy testing.

Want to understand your skin’s biology from the inside out? The Precision Peptide Genetic Test analyzes barrier and detox-pathway variants so you can bring genetic context to a conversation with your dermatologist.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Skin & Genetics education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.